Glucagon counteracts interleukin-6-dependent gene expression by redundant action of EPAC and PKA

Biological Chemistry

Volumn 392, Issue 12, 2011, Pages 1123-1134

  Khouri, Christina ^a   Dittrich, Anna ^a,b   Sackett, Sara Dutton ^c   Denecke, Bernd ^a   Trautwein, Christian ^c   Schaper, Fred ^a,b  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Acute phase response; Cross talk; Cytokine; Inflammation; Metabolism; Signal transduction

Indexed keywords

ANTIPORTER; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN ACTIVATED BY CYCLIC AMP; GLUCAGON; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PLACENTA PROTEIN 5; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; INFLAMMATION; LIVER CELL; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCAGON; GLYCOPROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEPATOCYTES; INTERLEUKIN-6; MALE; MICE; SIGNAL TRANSDUCTION;

MURINAE;

EID: 80755169632     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2011.171     Document Type: Article

References (34)

1. Andus, T., Geiger, T., Hirano, T., Kishimoto, T., Tran-Thi, T.A., Decker, K., and Heinrich, P.C. (1988). Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin-6 (BSF-2/IL-6) in hepatocyte primary cultures. Eur. J. Biochem. 173 , 287-293.
2. Bode, J.G., Fischer, R., H ä ussinger, D., Graeve, L., Heinrich, P.C., and Schaper, F. (2001). The inhibitory effect of IL-1 β on IL-6 induced α 2 -macroglobulin expression is due to activation of NF- κ B. J. Immunol. 167 , 1469-1481 (Pubitemid 32703146)
3. Chand, H.S., Foster, D.C., and Kisiel, W. (2005). Structure, function and biology of tissue factor pathway inhibitor-2. Thromb. Haemost. 94 , 1122-1130 (Pubitemid 41819605)
4. Christ, B., Nath, A., Heinrich, P.C., and Jungermann, K. (1994). Inhibition by recombinant human interleukin-6 of the glucagondependent induction of phosphoenolpyruvate carboxykinase and of the insulin-dependent induction of glucokinase gene expression in cultured rat hepatocytes: regulation of gene transcription and messenger RNA degradation. Hepatology 20 , 1577-1583.
5. DelGiudice, L.A. and White, G.A. (2009). The role of tissue factor and tissue factor pathway inhibitor in health and disease states. J. Vet. Emerg. Crit. Care 19 , 23-29.
6. Deon, D., Ahmed, S., Tai, K., Scaletta, N., Herrero, C., Lee, I.H., Krause, A., and Ivashkiv, L.B. (2001). Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fi broblasts. J. Immunol. 167 , 5395-5403. (Pubitemid 33009780)
7. Ehlting, C., Lai, W.S., Schaper, F., Brennd ö rfer, E.D., Matthes, R.J., Heinrich, P.C., Ludwig, S., Blackshear, P.J., Gaestel, M., H ä ussinger, D., et al. (2007). Regulation of suppressor of cytokine signaling 3 (SOCS3) mRNA stability by TNF- α involves activation of the MKK6/p38MAPK/MK2 cascade. J. Immunol. 178 , 2813-2826. (Pubitemid 46333159)
8. Ernst, M. and Jenkins, B.J. (2004). Acquiring signalling specifi city from the cytokine receptor gp130. Trends Genet. 20 , 23-32. (Pubitemid 38032817)
9. Gaudy, A.M., Clementi, A.H., Campbell, J.S., Smrcka, A.V., and Mooney, R.A. (2010). Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes. J. Biol. Chem. 285 , 41356-41365.
10. Hack, C.E., De Groot, E.R., Felt-Bersma, R.J., Nuijens, J.H., Strack Van Schijndel, R.J., Eerenberg-Belmer, A.J., Thijs, L.G., and Aarden, L.A. (1989). Increased plasma levels of interleukin-6 in sepsis. Blood 74 , 1704-1710. (Pubitemid 19251549)
11. Heinrich, P.C., Behrmann, I., Haan, S., Hermanns, H.M., Müller-Newen, G., and Schaper, F. (2003). Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374 , 1-20. (Pubitemid 37046923)
12. Heinrich, P.C., Behrmann, I., Müller-Newen, G., Schaper, F., and Graeve, L. (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334 , 297-314. (Pubitemid 28448572)
13. Hill, M. and McCallum, R. (1991). Altered transcriptional regulation of phosphoenolpyruvate carboxykinase in rats following endotoxin treatment. J. Clin. Invest. 88 , 811-816.
14. Hisaka, T., Lardeux, B., Lamireau, T., Wuestefeld, T., Lalor, P.F., Neaud, V., Maurel, P., Desmouliere, A., Kisiel, W., Trautwein, C., et al. (2004). Expression of tissue factor pathway inhibitor-2 in murine and human liver regulation during infl ammation. Thromb. Haemost. 91, 569-575. (Pubitemid 38396880)
15. Irizarry, R.A., Hobbs, B., Collin, F., Beazer-Barclay, Y.D., Antonellis, K.J., Scherf, U., and Speed, T.P. (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4 , 249-264
16. Kast, C., Wang, M., and Whiteway, M. (2003). The ERK/MAPK pathway regulates the activity of the human tissue factor pathway inhibitor-2 promoter. J. Biol. Chem. 278 , 6787-6794 (Pubitemid 36800667)
17. Lerner, L., Henriksen, M.A., Zhang, X., and Darnell, J.E., Jr. (2003). STAT3-dependent enhanceosome assembly and disassembly: synergy with GR for full transcriptional increase of the alpha 2-macroglobulin gene. Genes Dev. 17 , 2564-2577 (Pubitemid 37271426)
18. Mayo, K.E., Miller, L.J., Bataille, D., Dalle, S., Goke, B., Thorens, B., and Drucker, D.J. (2003). International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol. Rev. 55 , 167-194 (Pubitemid 36268402)
19. Michie, H.R. (1996). Metabolism of sepsis and multiple organ failure. World J. Surg. 20 , 460-464 (Pubitemid 26138594)
20. Oka, H., Chatani, Y., Hoshino, R., Ogawa, O., Kakehi, Y., Terachi, T., Okada, Y., Kawaichi, M., Kohno, M., and Yoshida, O. (1995). Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res. 55 , 4182-4187
21. Petersen, L.C., Sprecher, C.A., Foster, D.C., Blumberg, H., Hamamoto, T., and Kisiel, W. (1996). Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor. Biochemistry 35 , 266-272. (Pubitemid 26036431)
22. Pfaffl , M.W. (2001). A new mathematical model for relative quantifi-cation in real-time RT-PCR. Nucleic Acids Res. 29 , e45.
23. Plum, W., Tschaharganeh, D.F., Kroy, D.C., Corsten, E., Erschfeld, S., Dierssen, U., Wasmuth, H., Trautwein, C., and Streetz, K.L. (2010). Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fi brosis progression in a model of sclerosing cholangitis. Am. J. Pathol. 176 , 2236-2246
24. Radtke, S., Wüller, S., Yang, X.P., Lippok, B.E., Mütze, B., Mais, C., Schmitz-van de Leur, H.S., Bode, J.G., Gaestel, M., Heinrich, P.C., et al. (2010). Cross-regulation of cytokine signalling: pro-infl ammatory cytokines restrict IL-6 signalling through receptor internalisation and degradation. J. Cell Sci. 123 , 947-959
25. Sands, W.A., Woolson, H.D., Milne, G.R., Rutherford, C., and Palmer, T.M. (2006). Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol. Cell. Biol. 26 , 6333-6346 (Pubitemid 44277875)
26. Shapiro, P. (2002). Ras-MAP kinase signaling pathways and control of cell proliferation: relevance to cancer therapy. Crit. Rev. Clin. Lab. Sci. 39 , 285-330 (Pubitemid 35176967)
27. Shinoda, E., Yui, Y., Hattori, R., Tanaka, M., Inoue, R., Aoyama, T., Takimoto, Y., Mitsui, Y., Miyahara, K., Shizuta, Y., et al. (1999). Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells. J. Biol. Chem. 274 , 5379-5384 (Pubitemid 29109181)
28. Sivaraman, V.S., Wang, H., Nuovo, G.J., and Malbon, C.C. (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J. Clin. Invest. 99 , 1478-1483 (Pubitemid 27163797)
29. Sobota, R.M., Müller, P.J., Heinrich, P.C., and Schaper, F. (2008). Prostaglandin E1 inhibits IL-6-induced MCP-1 expression by interfering specifi cally in IL-6-dependent ERK1/2, but not STAT3, activation. Biochem. J. 412 , 65-72 (Pubitemid 351678336)
30. Sprecher, C.A., Kisiel, W., Mathewes, S., and Foster, D.C. (1994). Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proc. Natl. Acad. Sci. USA 91 , 3353-3357. (Pubitemid 24130235)
31. Stork, P.J. and Schmitt, J.M. (2002). Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 12 , 258-266. (Pubitemid 34634174)
32. Wilmore, D.W., Lindsey, C.A., Moyland, J.A., Faloona, G.R., Pruitt, B.A., and Unger, R.H. (1974). Hyperglucagonaemia after burns. Lancet 1 , 73-75.
33. Wong, C.M., Ng, Y.L., Lee, J.M., Wong, C.C., Cheung, O.F., Chan, C.Y., Tung, E.K., Ching, Y.P., and Ng, I.O. (2007). Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma. Hepatology 45 , 1129-1138. (Pubitemid 46775774)
34. Woolson, H.D., Thomson, V.S., Rutherford, C., Yarwood, S.J., and Palmer, T.M. (2009). Selective inhibition of cytokine-activated extracellular signal-regulated kinase by cyclic AMP via Epac1- dependent induction of suppressor of cytokine signalling-3. Cell. Signal. 21 , 1706-1715.